 |
Sculptra™
Sculptra is a synthetic injectable material known as poly-L-lactic acid (PLLA), a biocompatible and biodegradable material that has been widely used for many years in dissolvable suture material and soft tissue implants [surgical products]. Sculptra is not made from human or animal sources and does not require a skin test. Sculptra provides a gradual and significant increase in skin thickness, improving facial fullness/volume by reducing the appearance of folds and sunken areas.
Sculptra is FDA approved for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus. However, Sculptra may be used to improve the general volume loss (fat atrophy) associated with aging, with remarkable results. Sculptra is injected below the surface of the skin, in the area of fat loss, to soften and improve the appearance of facial contour irregularities, to treat nasolabial folds and marionette lines, and to enhance the fullness of the cheeks. People with mild volume loss will require fewer treatments than those with more severe volume loss; touch-up treatments may be needed to maintain the desired effects. The effects of Sculptra may last 2 years or longer. Poly-L-lactic acid (Sculptra™) has been safely used outside the United States since 1999 under the trade name New-Fill™. According to The American Society for Aesthetic Plastic Surgery, 44,696 Sculptra treatments were performed in the US in 2006; this was a 28% increase from the previous year.
Previous page
BOTOX® Cosmetic
Juvéderm™
Perlane®
Radiesse®
Restylane®
Sculptra™
|
|
